Effects of Using Convalescent Plasma Therapy in The Process of Treating COVID-19 Patients
-
Rambu Bangi Lokat(1*)
Universitas Nusa Cendana
-
Magdarita Riwu(2)
Universitas Nusa Cendana
-
Efrisca M. Br. Damanik(3)
Universitas Nusa Cendana
-
Elisabeth Levina Sari Setianingrum(4)
Universitas Nusa Cendana
(*) Corresponding Author
Abstract
Background :The high number of Covid-19 cases in Indonesia and the world, has forced the government and all health institutions to continue to seek treatment for Covid-19. Treatment for Covid-19 is still being pursued to provide the best therapy for Covid-19 patients, in this effort, one additional therapy is also given, namely convalescent plasma therapy for Covid-19 patients. The efficacy and safety of the use of convalescent plasma is currently still lacking definite evidence, so it is necessary to study the literature to see the results of existing studies to be reviewed Research Objectives : To find out what effects result from the use of convalescent plasma therapy in the treatment process for Covid-19 patients. Methods : This type of research is a literature review research that uses secondary data. Search literature through the PubMed and Google Scholar databases which are then selected according to the inclusion criteria set for review. The search results data obtained 26 journals according to research topics published in 2020-2021. All research results contained in the journal are arranged in a data extraction table. The results of the literature review were analyzed using topics that were in accordance with the objectives of the literature review based on findings from journals. Results : The results of a review of 26 journals on the use of convalescent plasma, found that 16 journals showed a positive effect in the use of convalescent plasma and there was also the use of convalescent plasma which had a negative effect in 10 journals of the review results . Conclusion : The literature review conducted in 26 journals in this study can be concluded that the effects that occur in the use of convalescent plasma therapy can be in the form of positive effects, namely an improvement in the patient's clinical symptoms and negative effects in the form of side effects of therapy and the lack of role of convalescent plasma therapy.
Downloads
References
2. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Tersedia : https://covid19.who.int/, diakses tanggal 6 Juni 2021
3. COVID-19 NTT Tersedia : http://covid19.nttprov.go.id/home, diakses tanggal 5 Juni 2021
4. Burhan E, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, et al. PEDOMAN TATALAKSANA COVID-19 Edisi 3 TIM EDITOR Perhimpunan Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan Dokter Anestesiologi dan Terap. 2020. 88–89 p.
5. Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma. JAMA - J Am Med Assoc. 2020;323(16):1582–9.
6. Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients with Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA - J Am Med Assoc. 2020 Aug 4;324(5):460–70.
7. Kementerian Kesehatan Republik Indonesia. Terapi Plasma Konvalesen, Harapan Baru Tangani COVID-19. Tersedia : https://www.kemkes.go.id/article/view/20090900001/terapi-plasma-konvalesen-harapan-baru-tangani-covid-19.html, diakses tanggal 15 Mei 2021
8. Sastroasmoro S, Ismael S. Dasar-dasar metode penelitian klinis. 2nd ed. Jakarta: CV Sagung Seto; 2002.
9. Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, et al. Use of convalescent plasma therapy in two covid-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci. 2020;35(14):2–9.
10. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020;117(17):9490–6.
11. Ye M, Fu D, Ren Y, Wang F, Wang D, Zhang F, et al. Treatment with convalescent plasma for COVID ‐ 19 patients in Wuhan , China.
12. Mohammed H, Hama-ali HH, Nasraddin S, Muhammad K, Amin K, Othman S, et al. Severe refractory COVID-19 patients responding to convalescent plasma ; A case series. Ann Med Surg. Tersedia : https://doi.org/10.1016/j.amsu.2020.06.018
13. Huang S, Shen C, Xia C, Huang X, Fu Y, Tian L. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in. 2020;1–9.
14. Joyner MJ, Marks P, Casadevall A, Joyner MJ, Wright RS, Fairweather D, et al. Early safety indicators of COVID-19 convalescent plasma in 5000 patients Early safety indicators of COVID-19 convalescent plasma in 5000 patients. 2020;130(9):4791–7.
15. Bar KJ, Siegel DL, Tebas P, Bar KJ, Shaw PA, Choi GH, et al. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. 2021;131(24):2–10.
16. Ibrahim D, Dulipsingh L, Zapatka L, Hussain, Eadie R, Crowell R, et al. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19 : A Prospective Phase II Clinical Trial. Infect Dis Ther. Tersedia : https://doi.org/10.1007/s40121-020-00341-2
17. Hu X, Hu C, Jiang D, Zuo Q, Li Y, Wang Y, et al. Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in. 2020;(December):1–12.
18. Gemİcİ A, Bİlgen H, Erdoğan C, Kansu A, Olmuşçelİk O. A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma. 2020;1781–5.
19. Allahyari A, Seddigh-Shamsi M, Mahmoudi M, Jamehdar SA, Amini M, Mozdourian M, et al. Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome. 2020;(January).
20. Avendaño-solá C, Duarte RF, Group C-S, Avendaño-solá C, Ramos-martínez A, Muñez-rubio E, et al. convalescent plasma in patients hospitalized with COVID-19 pneumonia A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. 2021;131(20).
21. Avendaño-Solà C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Molina RM de, Torres F, et al. Convalescent Plasma for COVID-19 : A multicenter , randomized clinical trial Authors : Affiliations : 2020;
22. Li L, Tong X, Chen H, He R, Lv Q, Yang R, et al. Original research. 2020;1–8.
23. O’Donnell MR, Grinsztejn B, Cummings MJ, Justman JE, Lamb MR, Eckhardt CM, et al. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021;131(13):1–9.
24. Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T. Convalescent plasma in the management of moderate covid-19 in adults in India : open label phase II multicentre randomised controlled trial ( PLACID Trial ). :1–10.
25. Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- research that is available on the COVID-19 resource centre - including this Treatment With Convalescent Plasma. 2020;(January).
26. Dai W, Wu J, Li T, Shen J, Pang R, Luo T, et al. Clinical outcomes for COVID ‐ 19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan , China.
27. Kurtz P, Righy C, Gadelha M, Bozza FA, Higa LM, Castilho L, et al. Effect of Convalescent Plasma in Critically Ill Patients With COVID-19 : An Observational Study. 2021;8(January):1–9.
28. Rogers R, Shehadeh F, Mylona EK, Rich J, Neill M, Touzard-romo F, et al. Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 ( COVID-19 ): A Matched Cohort Study. 2021;2019.
29. AlQahtani M, Abdulrahman A, Almadani A, Alali SY, Al Zamrooni AM, Hejab AH, et al. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease. Sci Rep [Internet]. 2021;11(1):1–8. Tersedia : https://doi.org/10.1038/s41598-021-89444-5
30. Korley FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, Davenport RD, Dumont LJ, et al. Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021;385(21):1951–60.
31. Siminovich V, Pratx burgos L, Scibona P, Beruto M, Vallone M, Vazques C, et al. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. 2021;619–29.
32. Bennett-Guerrero E, Romeiser JL, Talbot LR, Ahmed T, Mamone LJ, Singh SM, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial∗. Crit Care Med. 2021;1015–25.
33. Yoon H, Bartash R, Gendlina I, Rivera J, Nakouzi A, Bortz RH, et al. Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC. JCI Insight. 2021;6(4):1–14.
34. Yan M, Retna Indah S, Sefrina W, Made Ayu Lely S, Irmansyah. Uji Klinis Pemberian Plasma Konvalesen sebagai Terapi Tambahan Covid-19. Lap. KEMENKES RI Jakarta; 2020.
35. Transfusion Related Acute Lung Injury (TRALI) | FDA Tersedia : https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/transfusion-related-acute-lung-injury-trali, diakses tanggal 21 Desember 2022
36. Gharbharan A, Jordans CCE, Geurtsvankessel C, den Hollander JG, Karim F, Mollema FPN, et al. Convalescent Plasma for COVID-19. A randomized clinical trial. medRxiv. 2020;1–16.
37. WHO recommends against the use of convalescent plasma to treat COVID-19 Tersedia : https://www.who.int/news/item/07-12-2021-who-recommends-against-the-use-of-convalescent-plasma-to-treat-covid-19, diakses tanggal 22 Desember 2021
Copyright (c) 2023 Cendana Medical Journal (CMJ)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Notice
This work is licensed under a Creative Commons Attribution 4.0 International License.
